CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026

The $1000 Genome Odyssey

Scientists have discovered that the relationship between the human genome and disease has proven to be far more complicated than originally anticipated back in 2000, when Bill Clinton announced that the first human genome was sequenced by the Human Genome Project, and that diseases would be, from then on, much easier to cure. But as with any other field, the more we learn about something, the more we learn how little we actually know. Ivan Karabaliev at Eagle Genomics shares with you what he has found so far about the Holy Grail of genomic sequencing.

https://international-pharma.com/wp-content/uploads/2013/04/2-The-1000-Genome-Odyssey.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026